Contact Information
Company Information
Company
Liquidia Corporation
Annual Revenue
17500000.0
Technologies
Outlook
Drupal
Microsoft Azure
Active Campaign
Adobe Marketing Cloud
Remote
AI
Keywords
biopharmaceuticals
materials science
alternative energy films
nanotechnology
biotechnology: pharmaceutical preparations
health care
biotechnology research
biopharmaceutical
pulmonary arterial hypertension
pah
print technology
yutrepia
treprostinil inhalation powder
interstitial lung disease
ph-ild
drug delivery
innovative therapies
clinical outcomes
generic treprostinil injection
sustained-release formulation
l606
next-generation nebulizer
therapeutic development
clinical trials
research & development
pulmonary hypertension
biotech
biopharma
drug commercialization
healthcare providers
patient needs
precision medicine
innovative drug solutions
healthcare innovation
patient-centered therapies
regulatory approval
fda approval
therapeutic pipelines
healthcare investments
analyst coverage
investor relations
corporate governance
healthcare research
medical affairs
product launch
engineering solutions
medical devices
clinical efficacy
therapeutic areas
clinical development
rare diseases
clinical research
public health
health outcomes
therapeutic performance
drug formulations
investigational drugs
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans